A significant number of chronic pain patients have found pertinent
pain relief when using D-L phenylalanine. While DLPA often has
value for chronic pain disorders it has no value for acute pain.
This confirms that chronic and acute pain use somewhat different
mechanisms and pathways as these peripheral sensations are projected
to brain centers involved in the conscious perception of pain.
It is believed that the dextrorotatory phenylalanine which is
relatively inactive biologically is responsible for inhibiting
or preventing metabolic destruction of synaptic endorphine or
enkephaline. In that instance these naturally occurring neurotransmitters
will be more effective in blocking the transmission and perception
of pain.
A trial of 750 mgm of this D-L mixture t.i.d. can be used for
a week to check upon the clinical response. If no response occurs
the amount can be doubled for another week to be sure that enough
had been used. When relief has occurred a few patients can reduce
the amount required to maintain this relief. Some can even discontinue
its use for as long as a week before needing to begin its use
again.
It is of interest that this is a "pharmacologic" use of a large
dosage of this amino acid because the biolocally active levorotatory
compound is not effective in causing pain relief. Both versions
are easily metabolized and very safe to use in large doses. However,
since we are not using the D-phenylalanine to supplement intracellular
metabolic activity, the D-L phenylalanine amounts to a "non orthomolecular"
use of megadoses of a safe, non-toxic compound.
The patient is a 50 year old retired man whose major problem involved
a toxic sensitivity to industrial fumes. He was also sensitive
to several foods, particularly wheat, sodium glutamate in Chinese
dishes, also alcohol, especially white wines which could increase
his sense of exhaustion. He had chronic generalized pain in his
extremeties and particularly in his lumbar paraspinal area which
was caused by a non-union fracture of a lamella of the fifth lumbar
vertebrae.
The use of D-L phenylalanine, 750 mgm t.i.d. with meals had no
apparent effect for the first 4 days. On awakening the fifth day
he realized that he could roll over to get out of bed without
discomfort. He had become so inured to this level of pain that
he did not identify it even to himself as pain. During this time
he was using no alcohol since it would increase his physical complaints
when he felt depressed. Within 2 days he found that the chronic
low level pain in his extremities, especially hands and ankles,
had disappeared. Several days later he had a "special dinner"
out with his wife to celebrate this relief, and had 2 drinks.
He had pain in both achilles tendons and in the tendons of his
hands that evening and a return to his lower back pain the following
day. These pains were not so severe as previously, and were relieved
in one day by the continuing use of D-L phenylalanine. He has
subsequently found that the use of alcohol is consistently related
to a prompt recurrence of the tendon pains, and by low back pains
on the following day. He has found that when he increased his
physical activity and began to work on postponed projects that
he had acute aches and pains while getting into better physical
condition.
In short, he had a clear relief from chronic tendon and musculoskeletal
pain, with no relief from acute pains, including those which occur
while getting into better condition for increased physical efforts.
He was surprised to find that pain in his achilles and his finger
tendons could consistently recur, even though at decreased intensity,
when he drank socially. The depression which he was experiencing
at the start of therapy decreased as he was able to increase his
activity, and he returned to a "normal" level of moods within
a month of beginning to use the phenylalanine. This relief from
chronic pains has continued for over one year. He must maintain
dosage at the same level as when he began its use. If he reduces
the amount to 375 mgm t.i.d., or to 750 mgm HS alone, the chronic
pains return at a lower level of intensity in three days. When
he uses 750 mgm t.i.d. he can continue a normal activity in comfort
and good spirits.
Robert E. Buckley, M.D.